Literature DB >> 6723186

Kyphosis and pulmonary function in cystic fibrosis.

M M Logvinoff, G T Fon, L M Taussig, M J Pitt.   

Abstract

Spine deformity and chronic pulmonary disease are commonly seen in patients with cystic fibrosis (CF). In order to assess the prevalence of kyphosis, a retrospective evaluation of all initial standing chest radiographs of our CF patients matched with our "reference" population was undertaken. We also studied the possible correlation between the degree of kyphosis and the pulmonary function tests ( PFTs ), consisting of thoracic gas volume and maximal expiratory flows. In our population, the study confirmed an increased prevalence of kyphosis in CF patients (p less than .01), which occurred mostly in girls after 12 years of age (p less than .018). The kyphosis appeared to be, in most instances, of mild degree and was not related to any of the PFTs . No measurable increase of kyphosis was observed over a 3-year period in the group. Longer prospective study and the relationship of kyphosis to endocrine function in CF at puberty should be undertaken.

Entities:  

Mesh:

Year:  1984        PMID: 6723186     DOI: 10.1177/000992288402300705

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

Review 1.  Musculoskeletal and neuromuscular interventions: a physical approach to cystic fibrosis.

Authors:  Mary Massery
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

2.  Scoliosis Surgery in Cystic Fibrosis: Surgical Considerations and the Multidisciplinary Approach of a Rare Case.

Authors:  George I Mataliotakis; Athanasios I Tsirikos; Karen Pearson; Don S Urquhart; Carolyn Smith; Andrew Fall
Journal:  Case Rep Orthop       Date:  2016-06-19

3.  Thoracic Kyphosis is Now Uncommon Amongst Children and Adolescents with Cystic Fibrosis.

Authors:  Nicki Barker; Ashok Raghavan; Pauline Buttling; Kostas Douros; Mark Lloyd Everard
Journal:  Front Pediatr       Date:  2014-02-17       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.